Background and rationale behind the SU.VI.MAX Study, a prevention trial using nutritional doses of a combination of antioxidant vitamins and minerals to reduce cardiovascular diseases and cancers. SUpplementation en VItamines et Minéraux AntioXydants Study.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMID 9503043)

Published in Int J Vitam Nutr Res on January 01, 1998

Authors

S Hercberg1, P Galan, P Preziosi, A M Roussel, J Arnaud, M J Richard, D Malvy, A Paul-Dauphin, S Briançon, A Favier

Author Affiliations

1: Institut Scientifique et Technique de la Nutrition et de l'Alimentation/CNAM, Paris.

Articles citing this

Cross-sectional and longitudinal associations of different sedentary behaviors with cognitive performance in older adults. PLoS One (2012) 1.13

Use of multiple correspondence analysis and cluster analysis to study dietary behaviour: food consumption questionnaire in the SU.VI.MAX. cohort. Eur J Epidemiol (2001) 1.06

Use of food frequency questionnaire to assess relationships between dietary habits and cardiovascular risk factors in NESCAV study: validation with biomarkers. Nutr J (2013) 1.05

Nutrition, environment and cardiovascular health (NESCAV): protocol of an inter-regional cross-sectional study. BMC Public Health (2010) 0.91

Impact of cancer occurrence on health-related quality of life: a longitudinal pre-post assessment. Health Qual Life Outcomes (2004) 0.85

The role of selenium, vitamin C, and zinc in benign thyroid diseases and of selenium in malignant thyroid diseases: Low selenium levels are found in subacute and silent thyroiditis and in papillary and follicular carcinoma. BMC Endocr Disord (2008) 0.82

Alcohol consumption in midlife and cognitive performance assessed 13 years later in the SU.VI.MAX 2 cohort. PLoS One (2012) 0.80

Prospective association between the Dietary Inflammatory Index and mortality: modulation by antioxidant supplementation in the SU.VI.MAX randomized controlled trial. Am J Clin Nutr (2016) 0.79

Antioxidant vitamins and cardiovascular disease: Dr Jekyll or Mr Hyde? Am J Public Health (1999) 0.77

Effect of Multimorbidity on Health-Related Quality of Life in Adults Aged 55 Years or Older: Results from the SU.VI.MAX 2 Cohort. PLoS One (2016) 0.75

Articles by these authors

Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int (1997) 5.82

Are eukaryotic microorganisms clonal or sexual? A population genetics vantage. Proc Natl Acad Sci U S A (1991) 4.30

A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study--design, methods, and participant characteristics. SUpplementation en VItamines et Minéraux AntioXydants. Control Clin Trials (1998) 2.68

Effect of iron supplementation on the iron status of pregnant women: consequences for newborns. Am J Clin Nutr (1997) 2.44

Diet, antioxidant status, and smoking habits in French men. Am J Clin Nutr (1998) 2.41

Factors determining inpatient satisfaction with care. Soc Sci Med (2002) 2.29

Nano-emulsion formulation using spontaneous emulsification: solvent, oil and surfactant optimisation. Int J Pharm (2004) 2.23

EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol (1998) 2.08

Infection with Mayaro virus in a French traveller returning from the Amazon region, Brazil, January, 2010. Euro Surveill (2010) 1.94

Procedures associated with infective endocarditis in adults. A case control study. Eur Heart J (1995) 1.84

Compliance to drug treatment of patients with rheumatoid arthritis: a 3 year longitudinal study. J Rheumatol (1999) 1.70

Infective endocarditis in patients with negative blood cultures: analysis of 88 cases from a one-year nationwide survey in France. Clin Infect Dis (1995) 1.70

Serum beta-carotene and vitamin C as biomarkers of vegetable and fruit intakes in a community-based sample of French adults. Am J Clin Nutr (1997) 1.68

Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr (1995) 1.65

Characteristics of infective endocarditis in France in 1991. A 1-year survey. Eur Heart J (1995) 1.57

Bias and precision in visual analogue scales: a randomized controlled trial. Am J Epidemiol (1999) 1.56

Malaria risk perception, knowledge and prophylaxis practices among travellers of African ethnicity living in Paris and visiting their country of origin in sub-Saharan Africa. Trans R Soc Trop Med Hyg (2007) 1.53

The histone acetyltransferase, hGCN5, interacts with and acetylates the HIV transactivator, Tat. J Biol Chem (2001) 1.52

Acute infusions of bile salts increase biliary excretion of iron in iron-loaded rats. Gastroenterology (1991) 1.46

DNA damage induced in cells by gamma and UVA radiation as measured by HPLC/GC-MS and HPLC-EC and Comet assay. Chem Res Toxicol (2000) 1.45

Impact of trace elements and vitamin supplementation on immunity and infections in institutionalized elderly patients: a randomized controlled trial. MIN. VIT. AOX. geriatric network. Arch Intern Med (1999) 1.45

Vitamin B intake and status in healthy Havanan men, 2 years after the Cuban neuropathy epidemic. Br J Nutr (2001) 1.45

IANA task force on nutrition and cognitive decline with aging. J Nutr Health Aging (2007) 1.44

Serum concentrations of beta-carotene, vitamins C and E, zinc and selenium are influenced by sex, age, diet, smoking status, alcohol consumption and corpulence in a general French adult population. Eur J Clin Nutr (2005) 1.44

Iodine deficiency in France. Lancet (1999) 1.39

Risk factors for trachoma in Mali. Int J Epidemiol (2002) 1.38

The Groningen Activity Restriction Scale for measuring disability: its utility in international comparisons. Am J Public Health (1994) 1.38

A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group. Amyotroph Lateral Scler Other Motor Neuron Disord (2001) 1.36

Iron deficiency in Europe. Public Health Nutr (2001) 1.31

The comparative efficacy and tolerability of CGP 56697 (artemether + lumefantrine) versus halofantrine in the treatment of uncomplicated falciparum malaria in travellers returning from the Tropics to The Netherlands and France. Int J Antimicrob Agents (1999) 1.27

The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes. Int J Obes Relat Metab Disord (2000) 1.26

Long-term disability and prolonged sick leaves as outcome measurements in ankylosing spondylitis. Possible predictive factors. Arthritis Rheum (1990) 1.25

Factors influencing blood concentration of retinol, alpha-tocopherol, vitamin C, and beta-carotene in the French participants of the SU.VI.MAX trial. Eur J Clin Nutr (2006) 1.25

Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus. J Am Coll Nutr (2001) 1.22

Prion infection impairs the cellular response to oxidative stress. Proc Natl Acad Sci U S A (2000) 1.22

Metalloregulation of the tumor suppressor protein p53: zinc mediates the renaturation of p53 after exposure to metal chelators in vitro and in intact cells. Oncogene (2000) 1.21

The potential role of antioxidant vitamins in preventing cardiovascular diseases and cancers. Nutrition (1998) 1.21

Self-administered questionnaire compared with interview to assess past-year physical activity. Med Sci Sports Exerc (2000) 1.20

Indicators of abdominal adiposity in middle-aged participants of the SU.VI.MAX study: relationships with educational level, smoking status and physical inactivity. Diabetes Metab (2004) 1.20

Regulation of p53 by metal ions and by antioxidants: dithiocarbamate down-regulates p53 DNA-binding activity by increasing the intracellular level of copper. Mol Cell Biol (1997) 1.19

Role of cellular zinc in programmed cell death: temporal relationship between zinc depletion, activation of caspases, and cleavage of Sp family transcription factors. Biochem Pharmacol (2001) 1.18

Lipid peroxidation level and antioxidant micronutrient status in a pre-aging population; correlation with chronic disease prevalence in a French epidemiological study (Nantes, France). J Am Coll Nutr (1997) 1.18

Cognitive decline is associated with systemic oxidative stress: the EVA study. Etude du Vieillissement Artériel. J Am Geriatr Soc (2000) 1.18

Trachoma, flies and environmental factors in Burkina Faso. Trans R Soc Trop Med Hyg (2003) 1.18

Nonspecific effects in longitudinal studies: impact on quality of life measures. J Clin Epidemiol (1996) 1.17

Protective effects of hsp70 in inflammation. Experientia (1994) 1.16

Silica-associated connective tissue disease. A study of 24 cases. Medicine (Baltimore) (1995) 1.16

Nutritional anaemias. Baillieres Clin Haematol (1992) 1.15

Carotid intima-media thickness is slightly increased over time in HIV-1-infected patients. HIV Med (2005) 1.15

Hypertriglyceridemic waist and 7.5-year prospective risk of cardiovascular disease in asymptomatic middle-aged men. Int J Obes (Lond) (2006) 1.15

Impact of musculoskeletal disorders on quality of life: an inception cohort study. Ann Rheum Dis (2004) 1.13

Low incidence of rheumatoid arthritis in France. Scand J Rheumatol (1994) 1.11

Zinc homeostasis-regulating proteins: new drug targets for triggering cell fate. Curr Drug Targets (2003) 1.11

The influence of aging on plasma sex hormones in men: the Telecom Study. Am J Epidemiol (1992) 1.10

Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial. Ann Nutr Metab (1997) 1.10

Diet quality and dietary diversity in France: implications for the French paradox. J Am Diet Assoc (1996) 1.10

Nosocomial infections: prospective survey of incidence in five French intensive care units. Intensive Care Med (1998) 1.10

Age-related oxidative stress and antioxidant parameters in middle-aged and older European subjects: the ZENITH study. Eur J Clin Nutr (2005) 1.09

Determining factors in the iron status of adult women in the SU.VI.MAX study. SUpplementation en VItamines et Minéraux AntioXydants. Eur J Clin Nutr (1998) 1.09

Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999. Groupe d'Epidémiologie Clinique du Syndrome d'Immunodéficience Acquise en Aquitaine. Clin Infect Dis (2000) 1.09

Concentration of selected metals in normal and pathological human seminal plasma. J Trace Elem Electrolytes Health Dis (1988) 1.09

Determinants of thyroid volume in healthy French adults participating in the SU.VI.MAX cohort. Clin Endocrinol (Oxf) (2000) 1.08

[Amoebic liver abscess. Study of 20 cases with literature review]. Rev Med Interne (2003) 1.08

Prevalence and factors associated with renal impairment in HIV-infected patients, ANRS C03 Aquitaine Cohort, France. HIV Med (2009) 1.08

Quality of life profiles in the first years of rheumatoid arthritis: results from the EURIDISS longitudinal study. Arthritis Rheum (2001) 1.08

Body composition and fat repartition in relation to structure and function of large arteries in middle-aged adults (the SU.VI.MAX study). Int J Obes (Lond) (2005) 1.08

Dietary patterns in six european populations: results from EURALIM, a collaborative European data harmonization and information campaign. Eur J Clin Nutr (2000) 1.08

IgA nephropathy: prognostic classification of end-stage renal failure. L'Association des Néphrologues de l'Est. Nephrol Dial Transplant (1997) 1.08

Compliance with drug therapy in rheumatoid arthritis. A longitudinal European study. Joint Bone Spine (2000) 1.07

Artificial and natural ultraviolet radiation exposure: beliefs and behaviour of 7200 French adults. J Eur Acad Dermatol Venereol (2008) 1.07

Estimated risk of endocarditis in adults with predisposing cardiac conditions undergoing dental procedures with or without antibiotic prophylaxis. Clin Infect Dis (2006) 1.06